CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Mirna Therapeutics, Inc.  (MIRN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Mirna Therapeutics's Quick Ratio

MIRN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

MIRN Quick Ratio (Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Current Liabilities Change -90.21 % -76.87 % - - -
Y / Y Cash & cash equivalent Change -32.56 % 85.58 % - - -
Quick Ratio MRQ 167.58 57.47 49.63 65.04 24.33
Overall Ranking # 34 # 58 # 61 # 56 # 139
Seq. Current Liabilities Change -68.69 % -21.14 % 18 % -66.4 % -26.04 %
Seq. Cash & cash equivalent Change -8.69 % -8.68 % -9.97 % -10.17 % 151.28 %



Quick Ratio forth quarter 2016 Comment
Current Liabilities decreased faster than Mirna Therapeutics's Cash & cash equivalent, this led to improvement in Mirna Therapeutics's Quick Ratio to 167.58, Quick Ratio remained below Mirna Therapeutics, Inc. average.

Within Biotechnology & Drugs industry Mirna Therapeutics, Inc. achieved highest Quick Ratio than Mirna Therapeutics in forth quarter 2016. While Quick Ratio total ranking has improved so far to 34, from total ranking in previous quarter at 58.

Explain Quick Ratio?
What are MIRN Segments?
See Quick Ratio MIRN on the trailing twelve month basis
Quick Ratio forth quarter 2016 Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 34


Quick Ratio Statistics
High Average Low
167.58 61.87 7.16
(Dec 31 2016)   (Sep 30 2015)


You need to upgrade your Flash Player


Financial Statements
Mirna Therapeutics's Current Liabilities $ 0 Millions Visit MIRN's Balance sheet
Mirna Therapeutics's Cash & cash equivalent $ 60 Millions Visit MIRN's Balance sheet
Source of MIRN's Sales Visit MIRN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingDec 31 2016, within Biotechnology & Drugs Industry Quick RatioDec 31 2016 MRQ Cash & cash equivalentDec 31 2016 MRQ Current Liabilities
Mirna Therapeutics, Inc.  167.58 $ 60.498  Millions$ 0.361  Millions
Regenxbio Inc.  58.04 $ 89.554  Millions$ 1.543  Millions
Cadus Corp  37.12 $ 5.675  Millions$ 0.153  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
PNTTE's Profile
Stock Price
PNTTE's Financials
PNTTE's Expectations
Business Description
Fundamentals
Charts & Quotes
PNTTE's News
Suppliers
PNTTE's Competitors
Customers & Markets
Economic Indicators
PNTTE's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com